|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
US8258260B2
(en)
|
1970-02-11 |
2012-09-04 |
Immatics Biotechnologies Gmbh |
Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
|
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
NL154599B
(nl)
|
1970-12-28 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
|
|
US3901654A
(en)
|
1971-06-21 |
1975-08-26 |
Biological Developments |
Receptor assays of biologically active compounds employing biologically specific receptors
|
|
US3853987A
(en)
|
1971-09-01 |
1974-12-10 |
W Dreyer |
Immunological reagent and radioimmuno assay
|
|
US3867517A
(en)
|
1971-12-21 |
1975-02-18 |
Abbott Lab |
Direct radioimmunoassay for antigens and their antibodies
|
|
NL171930C
(nl)
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
|
US3850578A
(en)
|
1973-03-12 |
1974-11-26 |
H Mcconnell |
Process for assaying for biologically active molecules
|
|
US3935074A
(en)
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4034074A
(en)
|
1974-09-19 |
1977-07-05 |
The Board Of Trustees Of Leland Stanford Junior University |
Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
|
|
US3984533A
(en)
|
1975-11-13 |
1976-10-05 |
General Electric Company |
Electrophoretic method of detecting antigen-antibody reaction
|
|
US4036945A
(en)
|
1976-05-03 |
1977-07-19 |
The Massachusetts General Hospital |
Composition and method for determining the size and location of myocardial infarcts
|
|
US4098876A
(en)
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
|
US4289747A
(en)
|
1978-12-26 |
1981-09-15 |
E-Y Laboratories, Inc. |
Immunological determination using lectin
|
|
US4331647A
(en)
|
1980-03-03 |
1982-05-25 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4879219A
(en)
|
1980-09-19 |
1989-11-07 |
General Hospital Corporation |
Immunoassay utilizing monoclonal high affinity IgM antibodies
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5011771A
(en)
|
1984-04-12 |
1991-04-30 |
The General Hospital Corporation |
Multiepitopic immunometric assay
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
DE3751873T2
(de)
|
1986-04-09 |
1997-02-13 |
Genzyme Corp |
Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5281521A
(en)
|
1992-07-20 |
1994-01-25 |
The Trustees Of The University Of Pennsylvania |
Modified avidin-biotin technique
|
|
US20020150914A1
(en)
|
1995-06-30 |
2002-10-17 |
Kobenhavns Universitet |
Recombinant antibodies from a phage display library, directed against a peptide-MHC complex
|
|
EP0857176A1
(en)
|
1995-10-25 |
1998-08-12 |
Centocor B.V. |
HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE
|
|
AU5992999A
(en)
|
1998-10-02 |
2000-04-26 |
Ludwig Institute For Cancer Research |
Tumor antigens and ctl clones isolated by a novel procedure
|
|
US7157091B1
(en)
*
|
1999-06-18 |
2007-01-02 |
Ludwig Institute For Cancer Research |
MAGE-A1 peptides presented by HLA class II molecules
|
|
US7521202B2
(en)
|
1999-12-17 |
2009-04-21 |
The Board Of Regents Of The University Of Oklahoma |
Method and apparatus for the production of soluble MHC antigens and uses thereof
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
US20070099182A1
(en)
|
2000-10-10 |
2007-05-03 |
Hildebrand William H |
Comparative ligand mapping from MHC class I positive cells
|
|
US20090062512A1
(en)
|
2000-10-10 |
2009-03-05 |
Hildebrand William H |
Comparative ligand mapping from MHC class I positive cells
|
|
US20070026433A1
(en)
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
US6867283B2
(en)
|
2001-05-16 |
2005-03-15 |
Technion Research & Development Foundation Ltd. |
Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003216341A1
(en)
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
|
DE10225144A1
(de)
|
2002-05-29 |
2003-12-18 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
DE10313819A1
(de)
|
2003-03-24 |
2004-10-07 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
US7488793B2
(en)
|
2003-09-22 |
2009-02-10 |
Ludwig Institute For Cancer Research |
Isolated peptide which binds to HLA-Cw*07 and uses thereof
|
|
WO2005113595A2
(en)
|
2004-05-19 |
2005-12-01 |
Avidex Ltd |
High affinity ny-eso t cell receptor
|
|
DE102004026135A1
(de)
|
2004-05-25 |
2006-01-05 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
DK1758935T3
(da)
|
2004-05-26 |
2009-08-10 |
Immunocore Ltd |
Telomerase-T-cellereceptorer med höj affinitet
|
|
GB0411773D0
(en)
|
2004-05-26 |
2004-06-30 |
Avidex Ltd |
Method for the identification of polypeptides which bind to a given peptide mhc complex or cd 1-antigen complex
|
|
US20090226474A1
(en)
|
2004-05-27 |
2009-09-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
EP1642905B1
(en)
|
2004-10-02 |
2009-01-21 |
Immatics Biotechnologies GmbH |
Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
|
|
TW200636064A
(en)
|
2004-10-28 |
2006-10-16 |
Centocor Inc |
Anti-respiratory syncytial virus antibodies, antigens and uses thereof
|
|
CN105461802A
(zh)
|
2005-04-01 |
2016-04-06 |
英美偌科有限公司 |
高亲和力hiv t细胞受体
|
|
EP1717245B1
(en)
|
2005-04-26 |
2011-06-08 |
Immatics Biotechnologies GmbH |
T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
|
|
GB0524477D0
(en)
|
2005-11-30 |
2006-01-11 |
Avidex Ltd |
Isolated T cell receptors which specifically bind to vygfvracl-hla-24
|
|
GB0511124D0
(en)
|
2005-06-01 |
2005-07-06 |
Avidex Ltd |
High affinity melan-a t cell receptors
|
|
DE602005020046D1
(de)
|
2005-09-05 |
2010-04-29 |
Immatics Biotechnologies Gmbh |
Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden
|
|
ATE545708T1
(de)
*
|
2005-11-14 |
2012-03-15 |
Univ Laval |
Krebsantigen mage-a9 und verwendungen davon
|
|
WO2007143104A2
(en)
*
|
2006-06-01 |
2007-12-13 |
Receptor Logic, Ltd. |
Antibodies as t cell receptor mimics, methods of production and uses thereof
|
|
DE102007001370A1
(de)
*
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
CA2682093A1
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
|
NZ582823A
(en)
|
2007-07-27 |
2012-04-27 |
Immatics Biotechnologies Gmbh |
Composition of tumour-associated peptides and related anti-cancer vaccine
|
|
HUE025636T2
(en)
|
2007-07-27 |
2016-04-28 |
Immatics Biotechnologies Gmbh |
Novel immunogenic epitopes for immunotherapy
|
|
RS54204B1
(sr)
|
2007-07-27 |
2015-12-31 |
Immatics Biotechnologies Gmbh |
Nova imunoterapija protiv tumora mozga
|
|
WO2009026117A2
(en)
|
2007-08-16 |
2009-02-26 |
Glaxo Group Limited |
Novel compounds
|
|
WO2009090651A2
(en)
|
2008-01-15 |
2009-07-23 |
Technion Research And Development Foundation Ltd. |
Major histocompatibility complex hla-b2705 ligands useful for therapy and diagnosis
|
|
EP2113253B1
(en)
|
2008-04-30 |
2010-03-31 |
Immatics Biotechnologies GmbH |
Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
|
|
PT2119726E
(pt)
|
2008-05-14 |
2015-03-30 |
Immatics Biotechnologies Gmbh |
Novos e poderosos peptídeos para mhc classe ii derivados de survinina e neurocano
|
|
ES2536465T3
(es)
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
|
|
US20120077696A1
(en)
|
2009-03-15 |
2012-03-29 |
Technion Research And Development Foundation Ltd. |
Soluble hla complexes for use in disease diagnosis
|
|
ES2625985T3
(es)
|
2009-03-25 |
2017-07-21 |
Altor Bioscience Corporation |
Receptores de linfocitos T específicos de la vpr del VIH
|
|
GB0911566D0
(en)
|
2009-07-03 |
2009-08-12 |
Immunocore Ltd |
T cell receptors
|
|
CN102812043A
(zh)
|
2009-11-19 |
2012-12-05 |
新加坡国立大学 |
用于制备t细胞受体样单克隆抗体的方法及其用途
|
|
US9023802B2
(en)
|
2009-12-14 |
2015-05-05 |
Immatics Biotechnologies Gmbh |
HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201019331D0
(en)
|
2010-03-19 |
2010-12-29 |
Immatics Biotechnologies Gmbh |
Methods for the diagnosis and treatment of cancer based on AVL9
|
|
CA2798120A1
(en)
*
|
2010-04-30 |
2011-11-03 |
Paul P. Tamburini |
Antibodies having reduced immunogenicity in a human
|
|
DK2658872T3
(da)
*
|
2010-12-27 |
2020-10-12 |
Apo T B V |
Polypeptid, der binder aberrerende celler og inducerer apoptose
|
|
EA201401134A1
(ru)
|
2011-02-11 |
2015-05-29 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Hla-рестиктированные пептидоспецифические антигенсвязывающие белки
|
|
GB201103955D0
(en)
*
|
2011-03-09 |
2011-04-20 |
Antitope Ltd |
Antibodies
|
|
WO2015070061A1
(en)
|
2013-11-07 |
2015-05-14 |
Memorial Sloan-Kettering Cancer Center |
Anti-wt1/hla bi-specific antibody
|
|
ES2785081T3
(es)
|
2011-04-01 |
2020-10-05 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos biespecíficos similares a receptores de células T específicos para un péptido de WT1 presentado por HLA-A2
|
|
EP2802356A1
(en)
*
|
2012-01-13 |
2014-11-19 |
Apo-T B.V. |
Aberrant cell-restricted immunoglobulins provided with a toxic moiety
|
|
UA114108C2
(uk)
|
2012-07-10 |
2017-04-25 |
Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем |
Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
|
|
GB201223172D0
(en)
|
2012-12-21 |
2013-02-06 |
Immunocore Ltd |
Method
|
|
CA2934033A1
(en)
|
2013-11-07 |
2015-05-14 |
Memorial Sloan-Kettering Cancer Center |
Fc-enhanced anti-wt1/hla antibody
|
|
CN114456272A
(zh)
|
2015-04-03 |
2022-05-10 |
优瑞科生物技术公司 |
靶向afp肽/mhc复合体的构建体及其用途
|
|
US20180179283A1
(en)
|
2015-06-08 |
2018-06-28 |
Adicet Bio Inc. |
T cell receptor like antibodies having fine specificity
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
KR20200021074A
(ko)
*
|
2017-06-14 |
2020-02-27 |
아디셋 바이오, 인크. |
Hla 제한된 방식으로 hla-a2/tyrd를 결합할 수 있는 항체 및 이의 용도
|